What is the recommended dose of Brompheniramine (antihistamine) for an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brompheniramine Dosing for Adults

For adults, the recommended dose of brompheniramine is 10 mL (2 teaspoonfuls) or 4 mg every 4 hours, not exceeding 6 doses in 24 hours. 1

Standard Oral Dosing

  • Adults and patients ≥12 years: 10 mL (2 teaspoonfuls) every 4 hours, with a maximum of 6 doses per 24-hour period 1
  • This translates to approximately 4 mg per dose when using standard formulations 1
  • The dosing interval of every 4 hours is based on the drug's pharmacokinetic profile, though the actual half-life is considerably longer at approximately 25 hours 2

Sustained-Release Formulations

  • 12 mg sustained-release preparations are available and have been studied in clinical trials 3, 4, 5
  • These formulations are typically dosed twice daily (morning and evening) rather than every 4 hours 3
  • Sustained-release preparations may provide prolonged antihistaminic activity while potentially reducing the frequency of peak sedative effects 4

Clinical Efficacy Considerations

  • Brompheniramine demonstrates significant antihistaminic effects at serum concentrations of 7-10 ng/mL, which correspond to standard dosing regimens 2
  • The drug shows prolonged suppression of histamine-induced wheal and flare responses lasting up to 48 hours after a single dose, with significant pruritus suppression for 24 hours 2
  • In clinical trials for rhinovirus colds, 12 mg twice daily effectively reduced rhinorrhea, sneezing, and cough compared to placebo 6

Important Safety Considerations

  • Sedation is the primary adverse effect, typically lasting 6 hours after immediate-release formulations 3
  • Tolerance to drowsiness develops after repeated dosing (by day 2 of treatment) 3
  • The drug causes minimal objective impairment of psychomotor performance at therapeutic doses, though subjective drowsiness is common 3, 4
  • Sustained-release systems with non-linear drug release may cause more pronounced early sedation compared to linear-release systems 5

Practical Prescribing Algorithm

  1. For acute allergic symptoms: Start with 4 mg (10 mL) every 4 hours as needed, maximum 6 doses daily 1
  2. For chronic conditions requiring continuous coverage: Consider 12 mg sustained-release formulation twice daily (morning and evening) 3
  3. Monitor for sedation particularly during the first 2-6 hours after dosing 3, 4
  4. Advise patients that drowsiness typically improves with continued use after 1-2 days 3
  5. Avoid activities requiring alertness (driving, operating machinery) during the first few hours after dosing until individual response is known 4, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.